Elan Says It Has Cured Tysabri Contract Breach
Elan Corp. PLC claims to have cured a breach of a contract with Biogen Idec Inc., which would allow an $885 million Alzheimer's drug deal with Johnson & Johnson to go...To view the full article, register now.
Already a subscriber? Click here to view full article